» Articles » PMID: 25015077

Human Induced Pluripotent Stem Cell-derived Cardiomyocytes As an in Vitro Model for Coxsackievirus B3-induced Myocarditis and Antiviral Drug Screening Platform

Abstract

Rationale: Viral myocarditis is a life-threatening illness that may lead to heart failure or cardiac arrhythmias. A major causative agent for viral myocarditis is the B3 strain of coxsackievirus, a positive-sense RNA enterovirus. However, human cardiac tissues are difficult to procure in sufficient enough quantities for studying the mechanisms of cardiac-specific viral infection.

Objective: This study examined whether human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) could be used to model the pathogenic processes of coxsackievirus-induced viral myocarditis and to screen antiviral therapeutics for efficacy.

Methods And Results: hiPSC-CMs were infected with a luciferase-expressing coxsackievirus B3 strain (CVB3-Luc). Brightfield microscopy, immunofluorescence, and calcium imaging were used to characterize virally infected hiPSC-CMs for alterations in cellular morphology and calcium handling. Viral proliferation in hiPSC-CMs was quantified using bioluminescence imaging. Antiviral compounds including interferonβ1, ribavirin, pyrrolidine dithiocarbamate, and fluoxetine were tested for their capacity to abrogate CVB3-Luc proliferation in hiPSC-CMs in vitro. The ability of these compounds to reduce CVB3-Luc proliferation in hiPSC-CMs was consistent with reported drug effects in previous studies. Mechanistic analyses via gene expression profiling of hiPSC-CMs infected with CVB3-Luc revealed an activation of viral RNA and protein clearance pathways after interferonβ1 treatment.

Conclusions: This study demonstrates that hiPSC-CMs express the coxsackievirus and adenovirus receptor, are susceptible to coxsackievirus infection, and can be used to predict antiviral drug efficacy. Our results suggest that the hiPSC-CM/CVB3-Luc assay is a sensitive platform that can screen novel antiviral therapeutics for their effectiveness in a high-throughput fashion.

Citing Articles

Erbium oxide nanoparticles induce potent cell death, genomic instability and ROS-mitochondrial dysfunction-mediated apoptosis in U937 lymphoma cells.

Mohamed H, Elberry Y, Magdy H, Ismail M, Michael M, Eltayeb N Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40072553 DOI: 10.1007/s00210-025-03962-x.


Cardiomyopathy: pathogenesis and therapeutic interventions.

Huang S, Li J, Li Q, Wang Q, Zhou X, Chen J MedComm (2020). 2024; 5(11):e772.

PMID: 39465141 PMC: 11502724. DOI: 10.1002/mco2.772.


Human induced pluripotent stem cell-derived cardiomyocytes to study inflammation-induced aberrant calcium transient.

Tatekoshi Y, Chen C, Shapiro J, Chang H, Blancard M, Lyra-Leite D Elife. 2024; 13.

PMID: 39331464 PMC: 11434618. DOI: 10.7554/eLife.95867.


Macrophages enhance contractile force in iPSC-derived human engineered cardiac tissue.

Lock R, Graney P, Tavakol D, Nash T, Kim Y, Sanchez Jr E Cell Rep. 2024; 43(6):114302.

PMID: 38824644 PMC: 11254687. DOI: 10.1016/j.celrep.2024.114302.


Biodegradable suture development-based albumin composites for tissue engineering applications.

Naser M, Sayed A, Abdelmoez W, El-Wakad M, Abdo M Sci Rep. 2024; 14(1):7912.

PMID: 38575715 PMC: 10995150. DOI: 10.1038/s41598-024-58194-5.


References
1.
Kuhl U, Pauschinger M, Schwimmbeck P, Seeberg B, Lober C, Noutsias M . Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation. 2003; 107(22):2793-8. DOI: 10.1161/01.CIR.0000072766.67150.51. View

2.
Rotbart H . Treatment of picornavirus infections. Antiviral Res. 2001; 53(2):83-98. DOI: 10.1016/s0166-3542(01)00206-6. View

3.
Zuo J, Quinn K, Kye S, Cooper P, Damoiseaux R, Krogstad P . Fluoxetine is a potent inhibitor of coxsackievirus replication. Antimicrob Agents Chemother. 2012; 56(9):4838-44. PMC: 3421851. DOI: 10.1128/AAC.00983-12. View

4.
Noutsias M, Fechner H, de Jonge H, Wang X, Dekkers D, Houtsmuller A . Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections. Circulation. 2001; 104(3):275-80. DOI: 10.1161/01.cir.104.3.275. View

5.
Maron B, Doerer J, Haas T, Tierney D, Mueller F . Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009; 119(8):1085-92. DOI: 10.1161/CIRCULATIONAHA.108.804617. View